Sturm, L., Bettinger, D., Giesler, M., Boettler, T., Schmidt, A., Buettner, N., . . . Schultheiss, M. (2018). Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS). United European Gastroenterol J.

Sturm, Lukas, Dominik Bettinger, Max Giesler, Tobias Boettler, Arthur Schmidt, Nico Buettner, Robert Thimme, and Michael Schultheiss. "Treatment With Proton Pump Inhibitors Increases the Risk for Development of Hepatic Encephalopathy After Implantation of Transjugular Intrahepatic Portosystemic Shunt (TIPS)." United European Gastroenterol J 2018.

Sturm, Lukas, et al. "Treatment With Proton Pump Inhibitors Increases the Risk for Development of Hepatic Encephalopathy After Implantation of Transjugular Intrahepatic Portosystemic Shunt (TIPS)." United European Gastroenterol J 2018.